← Open Payments lookup

JAMES ADAMO: Open Payments

NPI 1851311021 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,082 in 311 payments from 26 companies in 2025. Trend: 2023 $6,780 · 2024 $5,050 · 2025 $6,082

Food & beverage: $6,075Education: $8
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.27$666
ABBVIE INC.24$494
Axsome Therapeutics, Inc.25$493
Vanda Pharmaceuticals Inc.21$481
Teva Pharmaceuticals USA, Inc.24$435
Otsuka America Pharmaceutical, Inc.18$426
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$415
Corium, LLC19$391
E.R. Squibb & Sons, L.L.C.22$384
Tris Pharma Inc18$260

Products named: INGREZZA, Auvelity, FANAPT, VRAYLAR, CAPLYTA, REXULTI, Azstarys, COBENFY.

Industry payments across MI — which companies pay providers there.